Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.


TSX:MDP - Post by User

Comment by snootchybootchyon Aug 04, 2021 11:03am
111 Views
Post# 33648118

RE:RE:RE:I am still holding onto my shares.

RE:RE:RE:I am still holding onto my shares.

Your posts again make zero sense. Just look back to what you said yesterday -- you said "this is a canadian company so very few, especially US investors, really follow the story" -- but now you say all investors seem to know what the CEO said. Which one is it?  Either everyone is listening to the CEO or nobody is. Those are literally opposite statements and both cannot be true, dummy.  Again, if investors thought the approval was in the bag, it would not have traded at only 1.5x TTM  revs so clearly not all investors believed the approval was a sure thing. Setbacks in the approval process were clearly priced in. This means some kind of recovery is in store as soon as there is some visibility in the duration of this setback.

<< Previous
Bullboard Posts
Next >>